By Editor , 29 October 2026
Appian and PSI CRO Launch AI Site Selection Tool for Trials

BERLIN – October 28, 2026 -- Appian (Nasdaq: APPN) and contract research organisation PSI have taken a live AI-powered process orchestration solution for clinical trial site identification and selection into operation, the first joint project between the two companies.

The solution covers therapeutic areas, indications and geographies. It moves previously manual, decentralised steps into a single digital process, from project initiation through the later stages of site selection.

By Editor , 21 September 2026
Appian Ranks #1 in Gartner's 2026 BOAT Critical Capabilities Report

McLean, Virginia – September 20, 2026 -- Appian (Nasdaq: APPN) ranked #1 for the Deterministic Workflow Automation Use Case and the Platform Consolidation Use Case in the 2026 Gartner Critical Capabilities for Business Orchestration and Automation Technologies (BOAT) report. The company was also named a Leader in the 2026 Gartner Magic Quadrant for BOAT, based on its Completeness of Vision and Ability to Execute.